Vorinostat and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT00310024 · COMPLETED
Trial details
- NCT number
- NCT00310024
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2008-02-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.